Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Michael A. Morse

Duke University Medical Center

Durham

USA

[email]@mc.duke.edu

Name/email consistency: high

[Claim this account]

Affiliations

Duke University Medical Center, Durham, USA. 2012
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. 1998 - 2010

References

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. Morse, M.A., Hanks, B.A., Suhocki, P., Doan, P.L., Liu, E.A., Frost, P., Bernard, S.A., Tsai, A., Moore, D.T., O'Neil, B.H. Clin. Colorectal. Cancer (2012) [Pubmed]
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. Morse, M.A., Hobeika, A.C., Osada, T., Berglund, P., Hubby, B., Negri, S., Niedzwiecki, D., Devi, G.R., Burnett, B.K., Clay, T.M., Smith, J., Lyerly, H.K. J. Clin. Invest. (2010) [Pubmed]
A year of successful cancer vaccines points to a path forward. Morse, M.A., Whelan, M. Curr. Opin. Mol. Ther. (2010) [Pubmed]
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Morse, M.A., Hobeika, A.C., Osada, T., Serra, D., Niedzwiecki, D., Lyerly, H.K., Clay, T.M. Blood (2008) [Pubmed]
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2. Morse, M.A., Hobeika, A., Osada, T., Niedzwiecki, D., Marcom, P.K., Blackwell, K.L., Anders, C., Devi, G.R., Lyerly, H.K., Clay, T.M. J. Transl. Med (2007) [Pubmed]
HER2 dendritic cell vaccines. Morse, M.A., Clay, T.M., Colling, K., Hobeika, A., Grabstein, K., Cheever, M.A., Lyerly, H.K. Clin. Breast Cancer (2003) [Pubmed]
Preparation of peptide-loaded dendritic cells for cancer immunotherapy. Morse, M.A., Clay, T., Colling, K., Lyerly, H.K. Mol. Biotechnol. (2003) [Pubmed]
Dendritic cell maturation in active immunotherapy strategies. Morse, M.A., Mosca, P.J., Clay, T.M., Lyerly, H.K. Expert. Opin. Biol. Ther (2002) [Pubmed]
CEA loaded dendritic cell vaccines. Morse, M.A., Clay, T.M., Lyerly, H.K. Cancer. Chemother. Biol. Response. Modif (2002) [Pubmed]
Technology evaluation: CEA-TRICOM, Therion Biologics Corp. Morse, M.A. Curr. Opin. Mol. Ther. (2001) [Pubmed]
Technology evaluation: gene therapy (IL-2), Valentis Inc. Morse, M.A. Curr. Opin. Mol. Ther. (2000) [Pubmed]
American Society of Clinical Oncology - 36th Annual Meeting. Morse, M.A. IDrugs (2000) [Pubmed]
Stem cell therapy (Aastrom Biosciences Inc). Morse, M.A. IDrugs (2000) [Pubmed]
Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials. Morse, M.A., Lyerly, H.K. Ann. Surg. Oncol. (1999) [Pubmed]
A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Morse, M.A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M.E., Lyerly, H.K. Clin. Cancer Res. (1999) [Pubmed]
Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc. Morse, M.A. Curr. Opin. Mol. Ther. (1999) [Pubmed]
Dendritic cell-based approaches to cancer immunotherapy. Morse, M.A., Lyerly, H.K. Expert. Opin. Investig. Drugs (1998) [Pubmed]
Immunotherapy of cancer using dendritic cells. Morse, M.A., Lyerly, H.K. Cytokines Cell. Mol. Ther. (1998) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.